BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 18357378)

  • 1. Myeloid leukemia-1 expression in benign and malignant melanocytic lesions.
    Wong RP; Khosravi S; Martinka M; Li G
    Oncol Rep; 2008 Apr; 19(4):933-7. PubMed ID: 18357378
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Minichromosome maintenance protein expression in benign nevi, dysplastic nevi, melanoma, and cutaneous melanoma metastases.
    Boyd AS; Shakhtour B; Shyr Y
    J Am Acad Dermatol; 2008 May; 58(5):750-4. PubMed ID: 18249467
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of cell cycle and apoptosis regulatory proteins and telomerase in melanocitic lesions.
    Batinac T; Hadzisejdić I; Brumini G; Ruzić A; Vojniković B; Zamolo G
    Coll Antropol; 2007 Jan; 31 Suppl 1():17-22. PubMed ID: 17469743
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic significance of activated Akt expression in melanoma: a clinicopathologic study of 292 cases.
    Dai DL; Martinka M; Li G
    J Clin Oncol; 2005 Mar; 23(7):1473-82. PubMed ID: 15735123
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fascin expression in melanocytic lesions of the skin.
    YILDIZ L; KEFELI M; AYDIN O; KANDEMIR B
    Eur J Dermatol; 2009; 19(5):445-50. PubMed ID: 19527987
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic significance of cytoplasmic p27 expression in human melanoma.
    Chen G; Cheng Y; Zhang Z; Martinka M; Li G
    Cancer Epidemiol Biomarkers Prev; 2011 Oct; 20(10):2212-21. PubMed ID: 21828232
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential expression of microtubule-associated protein 2 in melanocytic skin lesions.
    Gambichler T; Rotterdam S; Radkowski K; Altmeyer P; Kreuter A
    Am J Clin Pathol; 2009 May; 131(5):710-4. PubMed ID: 19369632
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of pHH3, Ki-67, and survivin immunoreactivity in benign and malignant melanocytic lesions.
    Nasr MR; El-Zammar O
    Am J Dermatopathol; 2008 Apr; 30(2):117-22. PubMed ID: 18360113
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunohistochemical analysis of Bcl-2 protein regulation in cutaneous melanoma.
    Tron VA; Krajewski S; Klein-Parker H; Li G; Ho VC; Reed JC
    Am J Pathol; 1995 Mar; 146(3):643-50. PubMed ID: 7534042
    [TBL] [Abstract][Full Text] [Related]  

  • 10. hTERT expression in melanocytic lesions: an immunohistochemical study on paraffin-embedded tissue.
    Fullen DR; Zhu W; Thomas D; Su LD
    J Cutan Pathol; 2005 Nov; 32(10):680-4. PubMed ID: 16293180
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of apoptosis regulators in cutaneous malignant melanoma.
    Tang L; Tron VA; Reed JC; Mah KJ; Krajewska M; Li G; Zhou X; Ho VC; Trotter MJ
    Clin Cancer Res; 1998 Aug; 4(8):1865-71. PubMed ID: 9717813
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Overexpression of p53 is a late event in the development of malignant melanoma.
    Lassam NJ; From L; Kahn HJ
    Cancer Res; 1993 May; 53(10 Suppl):2235-8. PubMed ID: 8485708
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nucleolin protein expression in cutaneous melanocytic lesions.
    Mourmouras V; Cevenini G; Cosci E; Epistolato MC; Biagioli M; Barbagli L; Luzi P; Mannucci S; Miracco C
    J Cutan Pathol; 2009 Jun; 36(6):637-46. PubMed ID: 19515042
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of the proteoglycans versican and mel-CSPG in dysplastic nevi.
    Touab M; Arumi-Uría M; Barranco C; Bassols A
    Am J Clin Pathol; 2003 Apr; 119(4):587-93. PubMed ID: 12710131
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cytoplasmic and nuclear expression of survivin in melanocytic skin lesions.
    Vetter CS; Müller-Blech K; Schrama D; Bröcker EB; Becker JC
    Arch Dermatol Res; 2005 Jul; 297(1):26-30. PubMed ID: 15906050
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Survivin protein in UVB induced apoptosis of melanoma cells and in melanoma progression.
    Zhang H
    Oncol Rep; 2005 Jun; 13(6):1121-6. PubMed ID: 15870931
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human oral cancers have altered expression of Bcl-2 family members and increased expression of the anti-apoptotic splice variant of Mcl-1.
    Mallick S; Patil R; Gyanchandani R; Pawar S; Palve V; Kannan S; Pathak KA; Choudhary M; Teni TR
    J Pathol; 2009 Feb; 217(3):398-407. PubMed ID: 19009587
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protein expression of carcinoembryonic antigen cell adhesion molecules in benign and malignant melanocytic skin lesions.
    Gambichler T; Grothe S; Rotterdam S; Altmeyer P; Kreuter A
    Am J Clin Pathol; 2009 Jun; 131(6):782-7. PubMed ID: 19461083
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of glucose-regulated stress protein GRP78 is related to progression of melanoma.
    Zhuang L; Scolyer RA; Lee CS; McCarthy SW; Cooper WA; Zhang XD; Thompson JF; Hersey P
    Histopathology; 2009 Mar; 54(4):462-70. PubMed ID: 19309398
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Loss of claudin-1 expression in tumor-associated vessels correlates with acquisition of metastatic phenotype in melanocytic neoplasms.
    Cohn ML; Goncharuk VN; Diwan AH; Zhang PS; Shen SS; Prieto VG
    J Cutan Pathol; 2005 Sep; 32(8):533-6. PubMed ID: 16115050
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.